Report Highlights
The global market for human reproductive technologies and products is valued at $16.1 billion in 2021 and is estimated to grow from $17.1 billion in 2022 to $24 billion in 2027 with a compound annual growth rate (CAGR) of 7% for the period of 2022-2027.
Report Includes
- 36 data tables and 22 additional tables
- An updated review of the global markets for human reproductive products and technologies
- Analyses of the global market trends, with data from 2020-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Evaluation and forecast the overall market size, projected growth trends, and corresponding market share analysis by treatment type, disease indication, end-user vertical, and geographic region
- In-depth information (facts and figures) concerning market drivers, market deterrents and other demographic and economic factors influencing the progress of this reproductive health market
- Discussion of the emerging technology trends, opportunities and gaps in the market estimating current and future demand for reproductive drugs and technologies, and COVID-19 implications within the marketplace
- Identification of promising new products and technologies still in the development and pipeline stage, and assess the probability that they will be commercialized successfully in the next five years
- Review of the company competitive landscape for global human reproductive drugs market, their product portfolios, global rankings, and company value share analysis based on segmental revenues
- Key merger and acquisition deals, new product launches, and other strategic alliances within the industry
- A relevant patent analysis
- Descriptive company profiles of the leading global players, including Actavis,Inc., Bayer AG, EMD Serono,Inc. and Quidel Corp.
Report Scope
The report is designed to be a comprehensive business tool to provide an in-depth look at the markets for reproductive drugs and technologies. The geographic scope of the report is global. The report reviews male and female reproductive health, presents standard pharmaceutical treatments and devices, and reviews technologies associated with reproductive health. The report also explores market size, identifies market participants, and investigates pipeline products and technologies.
The global market for reproductive technologies and products is divided into categories by treatment type and indication as follows.
Infertility market — male and female factors, pharmaceuticals, and future advancements.
- IVF.
- Assistive reproductive technologies.
- Fertility diagnostics.
Contraception — pharmaceuticals and devices.
Sexual dysfunction — pharmaceuticals and devices.
Each area is covered in detail, describing the disorder or treatment involved, identifying current products and treatments in the market in the base year 2021, measuring current market size and identifying current and potential market drivers, forecasting for 2027, assessing current and potential competitors, and identifying current competitor market shares for the base year of 2021.
Report Synopsis
Report Metrics | Details | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Base year considered | 2021 | ||||||||||||||||||
Forecast period considered | 2022–2027 | ||||||||||||||||||
Base year market size | $16.1 billion | ||||||||||||||||||
Market size forecast | $24.0 billion | ||||||||||||||||||
Growth rate | CAGR of 7.0% from 2022 to 2027 | ||||||||||||||||||
Units considered | $ Millions | ||||||||||||||||||
Segments covered | Region, Product Type | ||||||||||||||||||
Regions covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) | ||||||||||||||||||
Countries covered | U.S., Mexico., Canada., Germany., France., U.K., Italy., Spain., Rest of Europe (Switzerland, Denmark, Norway, Poland, Belgium, Austria, Netherlands, Sweden, Russia, etc.), Japan., China., India., Rest of Asia-Pacific (Australia, New Zealand, Taiwan, Singapore, Malaysia, Thailand, Philippines, Korea, Indonesia, etc.), (Middle East, Africa, South America). | ||||||||||||||||||
Key Market Drivers |
|
||||||||||||||||||
Companies studied |
|
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Regional Analysis of the Beauty and Personal Care Market: Middle East and North Africa (HLC305A)
- Global Biochip Markets: Microarrays and Lab-on-a-Chip (BIO049G)
- Contract Manufacturing: Global Markets to 2030 (MFG062B)
- Global Markets for Allergy Diagnostics and Treatments (PHM026D)
- Global Markets for Telemedicine Technologies (HLC014M)
Related Reports
Therapeutics for Women's Health: Technologies and Global Markets
The global therapeutics for women’s health technologies market is expected to grow from $61.5 billion in 2024 and is projected to reach $81.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.7% during the forecast period of 2024 to 2029.
U.S. Fertility Clinics Market
The U.S. market for fertility clinic services is estimated to increase from $8.9 billion in 2023 to reach $16.8 billion by 2028, at a compound annual growth rate (CAGR) of 13.6% from 2023 through 2028.
Global Semen Analysis Market
The global market for semen analysis should grow from $407.2 million in 2021 to $592.8 million by 2026, at a compound annual growth rate (CAGR) of 7.8% for the period of 2021-2026.
Drugs for Infertility: Global Markets to 2022
The global market for drugs for infertility should reach $4.2 billion by 2022 from $3.4 billion in 2017 at a compound annual growth rate (CAGR) of 4.3%, from 2017 to 2022.
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Regional Analysis of the Beauty and Personal Care Market: Middle East and North Africa
This report presents an in-depth analysis of the MENA beauty and personal care market, highlighting its current and future potential. It provides a detailed examination of market drivers, restraints, challenges, opportunities, and market projections for 2030.
Global Markets for Telemedicine Technologies
The global market for telemedicine technologies is projected to grow from $146.9 billion in 2025 to $251.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 11.3% from 2025 to 2030.
Thermo Fisher Scientific Inc.: 360° Company Analysis
This report provides a comprehensive analysis of Thermo Fisher Scientific Inc., covering key details such as key milestones/history, product offerings, technologies, major applications and end-user industries it serves.
Needle-Free Devices: Technologies and Global Markets
The global market for needle-free devices was valued at $15.5 billion in 2024 and is estimated to increase from $17.0 billion in 2025 to reach $27.7 billion by 2030, at a compound annual growth rate (CAGR) of 10.2% from 2025 through 2030.
Koninklijke Philips N.V.: 360° Company Analysis
The report discusses a 360° analysis of Koninklijke Philips N.V. It covers various aspects of Koninklijke Philips N.V., including products, business segments, history, distributors, and financial and strategic development.
Top Trending Reports
Next-Generation Advanced Batteries: Global Markets
The global market for next-generation advanced batteries is estimated to grow from $1.5 billion in 2024 to reach $5.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 28.5% from 2024 through 2029.
Global Pharmaceutical Drugs Industry: Competitive Landscape 2023
This report discusses the global pharmaceutical drugs industry and its competitive landscape in terms of significant player market ranking and top pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.
Biologic Therapeutic Drugs: Technologies and Global Markets
The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.
Global Markets and Manufacturing Technologies for Protein Drugs
The global protein drugs market is expected to grow from $441.7 billion in 2024 and is projected to reach $655.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.
Global Markets for Emerging Medical Device Technologies
The global market for emerging medical devices is estimated to increase from $136.6 billion in 2024 to reach $223.9 billion by 2029, at a compound annual growth rate (CAGR) of 10.4% from 2024 through 2029.
Report Highlights
The total market for reproductive technologies and products is estimated to achieve revenues of nearly $16.1 billion in 2013. In 2018, the forecasted revenues will likely reach $19.6 billion, demonstrating a compound annual growth rate (CAGR) of 4.1%.
Report Includes
- An overview of the market for human reproductive technologies.
- Analyses of market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
- Examinations of market sizes in the categories of infertility, artificial reproductive technologies, fertility diagnostics, contraception, and sexual dysfunction, with a division of markets according to treatment type and indication.
- Evaluations of pipeline products and technologies.
- Patent analysis.
Report Highlights
-
The total U.S. market for reproductive technologies and products is estimated to be $6.5 billion in 2004. In 2009, revenues will likely reach $9.8 billion, rising at an average annual growth rate (AAGR) of 8.6%.
-
Contraceptive products currently account for the highest amount of revenues and are expected to grow at an AAGR of 9.1% through the period.
-
Sexual dysfunction products are expected to show the highest annual growth at an average of 12.3% through 2009.
-
Few areas in medicine have posed so many social and ethical questions and attracted so much public attention as has assisted reproductive technology (ART) to manage infertility.
Report Highlights
-
The total U.S. market for human reproductive technologies reached $6.9 billion in 2001. It is expected to rise at an AAGR (average annual growth rate) of 10.1% to $11 billion in 2006.
-
Treatments for infertility will show the most dynamic growth during the forecast period among reproductive technology products. The market for infertility treatments, both pharmaceuticals and procedures, is expected to exhibit an average annual growth rate (AAGR) of 19.7% from 2001 to 2006. Approximately 28% of the market in 2001 was generated by fertility drugs and the remainder of the market was contributed by revenues from assisted reproductive technologies (ARTs), primarily in vitro fertilization (IVF).
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More